M&A Deal Summary |
|
---|---|
Date | 2006-06-29 |
Target | Medrad |
Sector | Medical Products |
Buyer(s) | Bayer |
Sellers(s) | Schering AG |
Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1863 |
Sector | Life Science |
Employees | 98,189 |
Revenue | 47.6B EUR (2023) |
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer was founded in 1863 and is based in Leverkusen, Germany.
DEAL STATS | # |
---|---|
Overall | 2 of 19 |
Sector (Medical Products) | 1 of 3 |
Type (Divestiture) | 1 of 2 |
State (Pennsylvania) | 1 of 1 |
Country (United States) | 1 of 9 |
Year (2006) | 1 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2003-08-15 |
Wipak Walothen
Bomlitz, Germany Wipak Group holds a rank in the development and manufacture of multilayer films (in particular barrier films) and high-end packaging solutions in Europe. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2006-07-06 |
Metrika
Sunnyvale, California, United States Metrika is a manufacturer and marketer of single-use diabetes monitoring products. Using proprietary technology, Metrika integrates miniaturized digital electronics, micro-optics, and dry reagent chemistries into easy-to-use hand-held, low-cost, single-use monitoring devices. |
Buy | $57M |
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Medical Products) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
State (Pennsylvania) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2006) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2000-01-12 |
Mitsui Pharmaceuticals
Tokyo, Japan Mitsui Pharmaceuticals is focusing on the three main areas of Oncology, Cardiovascular and Central Nervous System, providing a perfect strategic fit. Mitsui Pharmaceuticals's distinctive expertise and experience in the development of therapeutic products and its sales. |
Buy | - |